HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chih-Hsin Tang Selected Research

human ERBB2 protein

1/2022The impact of Angiopoietin-2 genetic polymorphisms on susceptibility for malignant breast neoplasms.
3/2021p-STAT3 expression in breast cancer correlates negatively with tumor size and HER2 status.
1/2020Downregulated METTL14 Expression Correlates with Breast Cancer Tumor Grade and Molecular Classification.
1/2020Combined High Resistin and EGFR Expression Predicts a Poor Prognosis in Breast Cancer.
1/2016Fascin-1 as a novel diagnostic marker of triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chih-Hsin Tang Research Topics

Disease

166Neoplasms (Cancer)
03/2024 - 04/2005
104Neoplasm Metastasis (Metastasis)
03/2024 - 04/2005
88Chondrosarcoma
03/2024 - 03/2008
41Osteoarthritis
01/2024 - 09/2007
39Rheumatoid Arthritis
02/2024 - 09/2007
37Inflammation (Inflammations)
11/2023 - 03/2010
31Osteosarcoma (Osteogenic Sarcoma)
10/2023 - 01/2004
24Prostatic Neoplasms (Prostate Cancer)
10/2022 - 09/2008
19Lung Neoplasms (Lung Cancer)
11/2023 - 12/2007
17Mouth Neoplasms (Oral Cancer)
07/2022 - 08/2008
15Arthritis (Polyarthritis)
06/2023 - 09/2007
15Breast Neoplasms (Breast Cancer)
01/2022 - 04/2005
14Experimental Arthritis
01/2024 - 07/2015
12Carcinogenesis
08/2023 - 04/2009
12Squamous Cell Carcinoma of Head and Neck
11/2022 - 07/2011
11Lymphatic Metastasis
12/2022 - 01/2013
11Hypoxia (Hypoxemia)
01/2020 - 10/2006
11Obesity
01/2020 - 11/2005
9Osteoporosis
03/2024 - 10/2007
8Infections
06/2023 - 10/2011
7Wilms Tumor (Wilm's Tumor)
01/2022 - 03/2011
6Bone Resorption
01/2021 - 06/2008
6Mitochondrial Diseases (Mitochondrial Disease)
01/2020 - 05/2010
5Carcinoma (Carcinomatosis)
01/2023 - 04/2005
5Triple Negative Breast Neoplasms
03/2021 - 11/2015
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

53Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2004
40CytokinesIBA
01/2024 - 06/2008
40IntegrinsIBA
11/2022 - 01/2004
31Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 02/2013
24Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2024 - 02/2009
24Matrix Metalloproteinases (MMPs)IBA
10/2023 - 09/2007
23NF-kappa B (NF-kB)IBA
09/2010 - 12/2007
22Small Interfering RNA (siRNA)IBA
01/2024 - 12/2007
20LigandsIBA
10/2023 - 10/2007
19AdipokinesIBA
03/2024 - 12/2014
19Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2021 - 09/2007
18ResistinIBA
08/2021 - 01/2015
16Messenger RNA (mRNA)IBA
11/2023 - 01/2008
15Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2007
14ChemokinesIBA
10/2023 - 09/2007
14MelatoninIBA
08/2023 - 01/2019
14Conditioned Culture MediaIBA
01/2023 - 01/2008
13CC ChemokinesIBA
07/2022 - 03/2009
12Vascular Endothelial Growth Factor CIBA
01/2023 - 01/2016
11Biomarkers (Surrogate Marker)IBA
01/2023 - 07/2011
11AdiponectinIBA
10/2021 - 10/2007
11Monoclonal AntibodiesIBA
01/2012 - 04/2005
11Integrin alphaVbeta3IBA
10/2009 - 04/2005
10Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2020 - 09/2010
9Nicotinamide PhosphoribosyltransferaseIBA
03/2024 - 03/2019
9LeptinIBA
08/2021 - 08/2008
8erucylphosphocholineIBA
01/2023 - 01/2016
8AmphiregulinIBA
01/2023 - 05/2015
8Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
11/2022 - 10/2014
8Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
06/2022 - 05/2013
8Chemokine CCL5IBA
06/2016 - 03/2009
7HMGB1 Protein (HMG1)IBA
11/2023 - 01/2016
7MicroRNAs (MicroRNA)IBA
10/2023 - 06/2014
7ApelinIBA
01/2023 - 03/2019
7EnzymesIBA
01/2023 - 03/2010
7ErbB Receptors (EGF Receptor)IBA
01/2023 - 11/2015
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2022 - 11/2012
7Peptides (Polypeptides)IBA
02/2022 - 02/2009
7Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 04/2012
72- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
01/2012 - 02/2009
6OsteopontinIBA
11/2022 - 06/2009
6Angiopoietin-2IBA
07/2022 - 10/2017
6Matrix Metalloproteinase 2 (Gelatinase A)IBA
08/2021 - 01/2013
6Phenobarbital (Luminal)FDA Link
03/2021 - 01/2016
6Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2018 - 06/2008
6Connective Tissue Growth FactorIBA
10/2017 - 05/2009
6Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2015 - 10/2006
6Protein Isoforms (Isoforms)IBA
01/2014 - 10/2007
6MAP Kinase Kinase Kinase 5IBA
07/2013 - 11/2008
5Cysteine (L-Cysteine)FDA Link
01/2023 - 10/2017
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 11/2008
5Matrix Metalloproteinase 13IBA
12/2022 - 02/2009
5human ERBB2 proteinIBA
01/2022 - 01/2016
5Interleukin-8 (Interleukin 8)IBA
01/2021 - 06/2008
5Glucose (Dextrose)FDA LinkGeneric
01/2021 - 02/2011
5Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2020 - 01/2012
5Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2013 - 02/2010
5U 0126 (UO 126)IBA
01/2012 - 02/2009
5Chemokine CXCL12IBA
10/2009 - 09/2007
4InterleukinsIBA
01/2024 - 06/2008
4Interleukin-18 (Interleukin 18)IBA
01/2024 - 01/2013
4Interleukin-17 (Interleukin 17)IBA
01/2024 - 02/2017
4Neutralizing AntibodiesIBA
01/2023 - 07/2013
4Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2014
4AntioxidantsIBA
12/2022 - 10/2013
4Adenosine Triphosphate (ATP)IBA
11/2022 - 06/2010
4Interleukin-1beta (Interleukin 1 beta)IBA
11/2022 - 10/2020
4Tyrosine Kinase InhibitorsIBA
01/2022 - 11/2015
4Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 11/2019
4Transcription Factors (Transcription Factor)IBA
08/2021 - 09/2007

Therapy/Procedure

30Therapeutics
11/2023 - 04/2005
20Drug Therapy (Chemotherapy)
08/2023 - 05/2010
16Radiotherapy
08/2023 - 05/2010
4Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2024 - 10/2013